-
Mashup Score: 0
Bernie Sanders may have reached the limits of his campaign to pressure pharmaceutical companies into lowering their prices.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Now weight-loss drug is linked to lower chance of MS - 18 day(s) ago
In the latest round of studies, doctors suggested the blockbuster medication – behind a now $80billion market – could lower the risk of multiple sclerosis (MS) by up to 80 percent and even ease sleep apnea in patients.
Source: www.dailymail.co.ukCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Now weight-loss drug is linked to lower chance of MS - 1 month(s) ago
In the latest round of studies, doctors suggested the blockbuster medication – behind a now $80billion market – could lower the risk of multiple sclerosis (MS) by up to 80 percent and even ease sleep apnea in patients.
Source: www.dailymail.co.ukCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2The new weight-loss drugs and cancer - 1 month(s) ago
There is much to consider when it comes to using the new semaglutide drugs for weight loss, especially for cancer patients. Fred Hutch experts weight in.
Source: www.fredhutch.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2The Science Behind Ozempic Was Wrong - 3 month(s) ago
The weight-loss effects of GLP-1 drugs have little to do with the gut.
Source: www.theatlantic.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Weighing the Cost - 4 month(s) ago
Albert Li on Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists and its potential effect on patients
Source: theophthalmologist.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0
The FDA is warning adults with diabetes to avoid using counterfeit semaglutide that may be circulating in the U.S. drug supply chain, according to a press release. The FDA said it is investigating the distribution of counterfeit 1 mg subcutaneous semaglutide (Ozempic, Novo Nordisk) and has seized thousands of units of the fake product. Products with the lot number NAR0074 and serial number
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0
The FDA is warning adults with diabetes to avoid using counterfeit semaglutide that may be circulating in the U.S. drug supply chain, according to a press release. The FDA said it is investigating the distribution of counterfeit 1 mg subcutaneous semaglutide (Ozempic, Novo Nordisk) and has seized thousands of units of the fake product. Products with the lot number NAR0074 and serial number
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0
The FDA is warning adults with diabetes to avoid using counterfeit semaglutide that may be circulating in the U.S. drug supply chain, according to a press release. The FDA said it is investigating the distribution of counterfeit 1 mg subcutaneous semaglutide (Ozempic, Novo Nordisk) and has seized thousands of units of the fake product. Products with the lot number NAR0074 and serial number
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6
FOX News contributor Dr. Marc Siegel says pausing weight loss medication over the holidays is not metabolically safe on ‘The Big Money Show.’
Source: www.foxbusiness.comCategories: General Medicine News, General HCPsTweet
Has Bernie Sanders reached the limit of his pharma bullying effort? - @STAT #Ozempic https://t.co/AAvOW8BMlK